Different occurrence of CD8+, CD45R0+, and CD68 + immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors

International Journal of Colorectal Disease

Volumn 17, Issue 1, 2002, Pages 25-29

  Oberg A ^a   Samii, S ^a   Stenling, R ^a   Lindmark, G ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CD45R0; CD68; CD8; Colorectal cancer

Indexed keywords

CD45RO ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD45RO; MONOCLONAL ANTIBODY CD68; OKT 8; UNCLASSIFIED DRUG; CD45 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE; ADENOCARCINOMA; COLORECTAL TUMOR; LYMPH NODE; LYMPHOCYTE; MACROPHAGE; MORTALITY; PATHOLOGY; SURVIVAL RATE;

ADENOCARCINOMA; AGED; ANTIGENS, CD45; ANTIGENS, CD8; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOCYTES; MACROPHAGES; MALE; PROGNOSIS; SURVIVAL RATE;

EID: 0036355045     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003840100337     Document Type: Article

References (13)

1. Lindmark G, Gerdin B, Pahlman L, Bergstrom R, Glimelius B (1994) Prognostic predictors in colorectal cancer. Dis Colon Rectum 37:1219-1227
2. UICC (1997) TNM. Classification of malignant tumours, 5th edn. Wiley, New York
3. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, et al (1995) Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 122:321-326
4. Banner BF, Savas L, Baker S, Woda BA (1993) Characterization of the inflammatory cell populations in normal colon and colonic carcinomas. Virchows Arch B Cell Pathol 64:213-220
5. Jass JR, Ajioka Y, Allen JP, Chan YF, Cohen RJ, Nixon JM, et al (1996) Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology 28:543-548
6. Ohtani H, Naito Y, Saito K, Nagura H (1997) Expression of costimulatory molecules B7-1 and B7-2 by macrophages along invasive margin of colon cancer: a possible antitumor immunity? Lab Invest 77:231-241
7. Cianchi F, Messerini E, Palomba A, Boddi V, Perigli G, Pucciani F, et al (1997) Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging? Dis Colon Rectum 40:1170-1175
8. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM (1997) Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182:318-324
9. + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58:3491-3494
10. McMillan DC, Fyffe GD, Wotherspoon HA, Cooke TG, McArdle CS (1997) Prospective study of circulating T-lymphocyte subpopulations and disease progression in colorectal cancer. Dis Colon Rectum 40:1068-1071
11. Palmqvist R, Oberg A, Bergstrom C, Rutegard JN, Zackrisson B, Stenling R (1998) Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer. Br J Cancer 77:917-925
12. Horst HA, Horny HP (1988) Cellular stromal reaction in lymph node metastases of human colorectal carcinomas. Hepatogastroenterology 35:140-143
13. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39